TUBA1C
| Official symbol: | TUBA1C |
| Full name: | tubulin alpha 1c |
| Location: | 12q13.12 |
| Also known as: | MGC14580, bcm948, TUBA6, MGC10851 |
| Entrez ID: | 84790 |
| Ensembl ID: | ENSG00000167553 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Expression restricted in 5 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 2 |
|
|
| Fusions detected in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
CRISPR: COMMON ESSENTIAL
|
|
|
| |
|
|
|
| Functional class: | Not specified |
| JensenLab PubMed score: | 10.01 (Percentile rank: 36.46%) |
| PubTator score: | 3.55 (Percentile rank: 23.96%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
